Taro Pharmaceutical
TARO
#5055
Rank
S$2.09 B
Marketcap
S$55.68
Share price
0.00%
Change (1 day)
4.74%
Change (1 year)

Taro Pharmaceutical (TARO) - Total debt

Total debt on the balance sheet as of March 2023 : S$2.52 Million

According to Taro Pharmaceutical's latest financial reports the company's total debt is S$2.52 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Taro Pharmaceutical - Total debt on balance sheet (from 1996 to 2023)

Total debt by year

Year Total debt Change
2023-03-31S$2.59 M-13.12%
2022-03-31S$2.98 M31.39%
2021-03-31S$2.27 M5.54%
2020-03-31S$2.15 M
2019-03-31N/A
2015-03-31S$8.08 M-64.03%
2014-03-31S$22.47 M-36.67%
2013-03-31S$35.49 M
2011-12-31S$57.87 M-24.39%
2010-12-31S$76.54 M-66.7%
2009-12-31S$0.22 B-14.51%
2008-12-31S$0.26 B-13.77%
2007-12-31S$0.31 B-14.6%
2006-12-31S$0.36 B-16.27%
2005-12-31S$0.43 B-0.72%
2004-12-31S$0.43 B28.96%
2003-12-31S$0.34 B242%
2002-12-31S$99.59 M4.46%
2001-12-31S$95.34 M17.7%
2000-12-31S$81 M40.12%
1999-12-31S$57.81 M6.44%
1998-12-31S$54.31 M8.11%
1997-12-31S$50.24 M51.48%
1996-12-31S$33.16 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
S$78.85 B 3,120,310.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$53.61 B 2,121,643.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$59.34 B 2,348,361.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$22.12 B 875,438.46%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
S$30.92 B 1,223,592.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
S$41.49 B 1,642,053.85%๐Ÿ‡จ๐Ÿ‡ญ Switzerland